Industry Strength Score
50/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
GUARDANT HEALTH INC (1GH.MI) Stock Price & Overview
BIT:1GH • US40131M1099
Current stock price
75.43 EUR
-1.13 (-1.48%)
Last:
The current stock price of 1GH.MI is 75.43 EUR. Today 1GH.MI is down by -1.48%.
1GH.MI Key Statistics
- Market Cap
- 9.894B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.88
- Dividend Yield
- N/A
1GH.MI Stock Performance
Today
-1.48%
1 Week
-17.72%
1 Month
N/A
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
1GH.MI Stock Chart
1GH.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1GH.MI.
Chartmill TA Rating
Chartmill Setup Rating
1GH.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1GH.MI. The financial health of 1GH.MI is average, but there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1GH.MI Earnings
On February 19, 2026 1GH.MI reported an EPS of -1 and a revenue of 281.27M. The company missed EPS expectations (-38.56% surprise) and beat revenue expectations (0.76% surprise).
Next Earnings DateApr 30, 2026
Last Earnings DateFeb 19, 2026
PeriodQ4 / 2025
EPS Reported-$1.00
Revenue Reported281.266M
EPS Surprise -38.56%
Revenue Surprise 0.76%
1GH.MI Forecast & Estimates
34 analysts have analysed 1GH.MI and the average price target is 115.99 EUR. This implies a price increase of 53.77% is expected in the next year compared to the current price of 75.43.
For the next year, analysts expect an EPS growth of 17.14% and a revenue growth 30.9% for 1GH.MI
Analysts
Analysts85.88
Price Target115.99 (53.77%)
EPS Next Y17.14%
Revenue Next Year30.9%
1GH.MI Financial Highlights
Over the last trailing twelve months 1GH.MI reported a non-GAAP Earnings per Share(EPS) of -2.88. The EPS increased by 5.62% compared to the year before.
Income Statements
Revenue(TTM)982.02M
Net Income(TTM)-416.28M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.67% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%-11.11%
Sales Q2Q%39.37%
EPS 1Y (TTM)5.62%
Revenue 1Y (TTM)32.88%
1GH.MI Ownership
Ownership
Inst Owners100.86%
Shares131.17M
Float125.73M
Ins Owners3.99%
Short Float %N/A
Short RatioN/A
1GH.MI Industry Overview
1GH.MI operates in the Health Care Services sub-industry within the Health Care sector. This group contains 50 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
88/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
43%
Outperformed 43% of sub-industries
3 Month Rank
57%
Outperformed 57% of sub-industries
6 Month Rank
50%
Outperformed 50% of sub-industries
Industry Fundamentals & Breadth
- Members
- 50
- New Highs
- 10%
- New Lows
- 2%
- Average ROE
- 10.1%
- Average Profit Margin
- 2.8%
- Average Operating Margin
- 5.3%
- Average P/E
- 40.9
- Average Fwd P/E
- 26.7
- Average Debt/Equity
- 0.8
1GH.MI Competitors/Peers
The largest stocks on the EU markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FRE | FRESENIUS SE & CO KGAA | 11.18 | 22.975B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.25 | 11.358B | ||
| EUK | EUKEDOS SPA | N/A | 14.554M | ||
| V3V | FAMICORD AG | N/A |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1GH.MI
Company Profile
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 2,490 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
Company Info
IPO: 2018-10-04
GUARDANT HEALTH INC
3100 Hanover Street
Palo Alto CALIFORNIA US
Employees: 2490
Phone: 18556988887
GUARDANT HEALTH INC / 1GH.MI FAQ
What does 1GH do?
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 2,490 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
What is the stock price of GUARDANT HEALTH INC today?
The current stock price of 1GH.MI is 75.43 EUR. The price decreased by -1.48% in the last trading session.
Does GUARDANT HEALTH INC pay dividends?
1GH.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1GH stock?
1GH.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists 1GH stock?
1GH.MI stock is listed on the Euronext Milan exchange.
Can you provide the growth outlook for GUARDANT HEALTH INC?
The Revenue of GUARDANT HEALTH INC (1GH.MI) is expected to grow by 30.9% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.